Increased HAT activity in Hpse-high myeloma cells resulted in upregulation of transcription of multiple genes (i.e., VEGF, HGF, MMP-9, RANKL) that drive an aggressive tumor phenotype [36]. This evidence concerns the gene MMP9 and plasma cell myeloma.